calendar
29,113 catalysts · 9,642 approval · 5,000 device 510k · 4,728 grant · 2,952 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
29,113 catalysts · 9,642 approval · 5,000 device 510k · 4,728 grant · 2,952 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: RECORDATI RARE. Form: TABLET. Route: ORAL
Sponsor: YILING. Form: CAPSULE. Route: ORAL
Sponsor: PFIZER. Form: CAPSULE. Route: ORAL
Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: CREEKWOOD PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: RHODES PHARMS. Form: TABLET. Route: SUBLINGUAL
Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: ABBVIE INC. Form: VIAL
Sponsor: PH HEALTH. Form: FOR SOLUTION. Route: ORAL
Sponsor: PH HEALTH. Form: FOR SOLUTION. Route: ORAL
Sponsor: PH HEALTH. Form: FOR SOLUTION. Route: ORAL
Sponsor: ADIENNE SA. Form: POWDER. Route: INTRAVENOUS
Sponsor: INSMED INC. Form: SUSPENSION, LIPOSOMAL. Route: INHALATION
Sponsor: VISTAPHARM LLC. Form: TABLET. Route: ORAL
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: POWDER. Route: IV (INFUSION)
Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INJECTION
Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL
Sponsor: AMGEN. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE. Form: LIQUID. Route: INHALATION
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: GE HLTHCARE INC. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: ALKEM. Form: CAPSULE. Route: ORAL
Sponsor: ALKEM. Form: CAPSULE. Route: ORAL
Sponsor: PIRAMAL CRITICAL. Form: LIQUID. Route: INHALATION
Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: ASTRAZENECA UK LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INJECTION
Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INJECTION
Sponsor: ZYDUS PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: CELGENE CORP. Form: POWDER. Route: SUBCUTANEOUS
Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL
Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL
Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL